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Summary. We investigated the ability of urinary 
neopterin concentrations and T-cell subset data, 
and their ratios to discriminate between anti-HIV- 
1 seronegatives, seropositives, and AIDS cases. Us- 
ing receiver-operated-characteristics curves, neop- 
terin levels were shown to provide the best discrim- 
ination. Of the ratios derived from the single vari- 
ables, neopterin per CD4 + cell counts and neop- 
terin per CD4+/CD8+ cell ratio were superior 
to the CD4 +/CD8 + cell ratio. Multivariate anal- 
yses were performed using a generalized likelihood 
ratio approach as well as linear discriminant analy- 
sis. The combination of neopterin concentration 
and CD4 + T-cell count is well suited to discrimi- 
nate between various stages of HIV-I infection 
and, therefore, we recommend using more than 
one assay to evaluate disease progression. 
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Classification 
In subjects infected with human immunodeficiency 
virus type 1 (HIV-1), particularly in those free of 
overt clinical symptoms, staging and individual 
prognosis are important issues. Quantitation of T- 
cell subsets is widely employed for monitoring 
those infected with the HIV-1 virus, but changes 
are predominantly seen in later stages of the dis- 
ease [5]. Increased concentrations of neopterin, a 
sensitive marker for the activation of the cell-me- 
diated immune system, have been consistently 
found in HIV-I infected individuals [6]. 
Abbreviations. HIV-1 = Human immunodeficiency virus type 1 ; 
AIDS = acquired immunodeficiency s ndrome; ROC = receiver 
operated characteristics; LR = likelihood ratio 
In a cohort of Austrian homosexual men we 
have compared the behavior of neopterin concen- 
trations in urine with T-cell subset data with regard 
to the discrimination between anti-HIV-1 serone- 
gative and seropositive individuals [7]. Here we ex- 
tend this study on another cohort: concentrations 
of neopterin in urine of American homosexual men 
were compared with T-cell subpopulation data and 
with several derived variables. We studied the po- 
tential of six single or composite variables to dis- 
criminate between three clinical conditions: anti- 
HIV-1 seronegatives, anti-HIV-1 seropositives, 
and patients with overt AIDS. Notably, our study 
is not meant to replace serological testing. Rather, 
the roles of the studied variables, singly or com- 
bined, in different stages of the disease course 
should be better defined. 
Methods 
A cohort of 150 homosexual men was enrolled in 
the spring of 1982 as consecutive patients of three 
primary care physicians in Washington, D.C., and 
Manhattan, New York. Detailed patients charac- 
teristics were previously published [9, 10]. Using 
samples collected during follow-up between April 
and August 1986, urinary neopterin concentrations 
were measured at Innsbruck, Austria, by an HPLC 
method (for review of analytical techniques, see 
Wachter [16]). An analysis of the predictive poten- 
tial of neopterin levels in these patients has already 
been published [11]. 
For the present evaluation, we have included 
a subset of 144 of the 150 patients for whom com- 
plete records were available on concomitant mea- 
surements of neopterin, CD4 +, and CD8 + T-cell 
number. 
The patients were grouped into three categories 
for the present evaluation: 71 who were anti- 
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HIV-1 seronegative at the time of sample collec- 
tion, 64 anti-HIV-1 seropositives, and 9 individ- 
uals in whom overt AIDS was diagnosed at latest 
by the end of 1986 (5 of these had diagnosis of 
AIDS before the 1986 sample collection; in 4 sub- 
jects, AIDS was diagnosed within a few weeks after 
this investigation). In these 9 men, AIDS diagnosis 
was made due to occurrence of severe opportun- 
istic infections; none of the patients, however, had 
a malignant disease. 
Statistical Methods 
In a first step, we computed for each of the three 
possible pairs of diagnostic ategories (i.e., serone- 
gatives vs seropositives, seronegatives vs AIDS 
cases, and seropositives v  AIDS cases), diagnostic 
sensitivities and specificities for each of the six in- 
vestigated variables, using subsequently all mea- 
sured values as cut-off limits. From these data, 
receiver operating characteristics (ROC) curves 
were constructed. As an aggregate measure for the 
diagnostic value, also the Youden index (sensitivi- 
ty+specif ic i ty-  1) was computed as a function of 
the variable investigated. 
Second, we used a recently published procedure 
[13] for multivariate analysis of the potential of 
the variables to differentiate between the three di- 
agnostic categories. This method yields formulae 
for estimating posterior probabilities for each diag- 
nostic category, based on pretest probabilities for 
the categories and on weighting factors for labora- 
tory test results (or other covariates). The weight- 
ing factors are obtained by logistic regression anal- 
ysis. Briefly, for each pair of diagnostic ategories, 
likelihood ratio functions are computed for single 
or combined laboratory (or clinical) tests by the 
logistic regression technique [1]. These functions 
are then used to convert pretest probabilities into 
posttest probabilities using a technique suited for 
more than two diagnostic ategories [2]. The log- 
istic regression analyses were performed using the 
BMDP computer software (program BMDPLR). 
For comparison, classical linear discriminant anal- 
yses were done using program BMDP7M. Statisti- 
cal comparisons of frequencies (e.g., frequencies 
of correct classifications, or estimated indices of 
diagnostic value) were made using the following 
transformation: 
z = (I arcsin 
-- arcsin ]/~z I)/(28.648 1/(1/n~ + 1/n2)), 
where Pl, P2 are the two frequences to be com- 
pared, and nl and n 2 are the numbers of observa- 
tions from which the frequency estimates were de- 
rived [15]. The z-values were assumed to follow 
a standard normal distribution. 
Results 
Differentiation Between Two Diagnostic Categories 
by Single or Composite Variables 
Markedly higher mean neopterin concentrations 
and lower mean CD4 + T-cell numbers were noted 
among the HIV-1 seropositives, particularly those 
with AIDS (Table 1). ROC curves were computed 
for the three single and the three composite vari- 
ables. The results for the differentiation between 
Table 1. Measurement results and composite variables obtained in various diagnostic ategories (figures 
are mean values, with range in parentheses) 
Variable" Anti-HIV-1 Anti-HIV-1 Patients with 
seronegatives seropositives AIDS 
(n = 71) (n = 64) (n = 9) 
Neopterin 126 (59, 587) 317 (84, 1316) 900 (445, 1877) 
CD4+ T-cells 1034 (421, 1921) 620 (155, 1359) 225 (38, 550) 
CD8 + T-cells 759 (294, 1313) 846 (335, 2365) 632 (143, 1316) 
CD4 +/CD8 + 
T-cell ratio 1.43 (0.61, 3.14) 0.77 (0.22, 1.83) 0.41 (0.18, 0.70) 
Neopterin per 
CD4+ T-cells 0.139 (0.050, 1.142) 0.632 (0.138, 3.71) 9.44 (0.81, 28.6) 
Neopterin per 
CD4+/CD8 + ratio 95 (31,336) 519 (99, 2978) 2608 (779, 6025) 
a Neopterin in urine: gmol per mol creatinine; CD4§ and CD8 + T-cell numbers per gl of peripheral 
blood 
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Figs. 1 a, b. ROC curves for discrimination between anti-HIV-1 
seronegatives versus seropositives (I vs II) and seropositives 
versus AIDS cases (II vs III). A line following the equation 
sensitivity = 1-  specificity would indicate a worthless test; the 
larger the deviation from this line (and the larger the area under 
the ROC curve) the better is the discriminative power of the 
test under scrutiny. Note that the results for the contrast II 
versus III can be regarded only as preliminary, since the number 
of AIDS cases in this study was very low a ROC curves for 
the single variables: urinary neopterin (solid line), CD4 + T-cell 
counts (-  -), and CD8 + T-cell counts (. . . . .  ) b ROC curves 
for the composite variables: neopterin per CD4 +/CD8 + T-cell 
ratio (solid line), neopterin per CD4+ T-cell count (-  - -), and 
CD4 +/CD8 + T-cell ratio ( . . . . .  ) 
Table 2. Diagnostic sensitivity and specificity for each variable, 
when pairwise comparisons between diagnostic lasses are per- 
formed. Results are recorded at cut-off values defined by maxi- 
mal Youden index 
Variable a Groups compared 
Seronegatives Seropositives 
vs sero- vs AIDS cases 
positives 
1. Neopterin 
Optimal cut-off 168 445 
Sensitivity 0.89 1.00 
Specificity 0.90 0.84 
2. CD4 + T-cells 
Optimal cut-off 859 355 
Sensitivity 0.86 0.89 
Specificity 0.72 0.88 
3. CD8 + T-cells 
Optimal cut-off 925 483 
Sensitivity 0.38 0.56 
Specificity 0.79 0.98 
4. CD4+/CD8+ T-cell ratio 
Optimal cut-off 1.068 0.587 
Sensitivity 0.88 0.89 
Specificity 0.86 0.77 
5. Neopterin per CD4 + 
T-cell number 
Optimal cut-off 0.25 1.64 
Sensitivity 0.84 0.89 
Specificity 0.97 0.94 
6. Neopterin per CD4+/CD8 + 
T-cell ratio 
Optimal cut-off 199 779 
Sensitivity 0.88 1.00 
Specificity 0.99 0.84 
"Units see Table 1 
anti-HIV-I seronegatives versus seropositives and 
between seropositives and AIDS cases are shown 
in Fig. 1. Neopterin showed the greatest potential 
for differentiating anti-HIV-1 seronegatives and 
seropositives. For the differentiation of seroposit- 
ives and AIDS cases, CD4+ T-cell number and 
neopterin had similar efficiency. In contrast, the 
CD8 + T-cell number did not discriminate between 
the diagnostic ategories (Fig. 1 a). 
Of the composite variables (Fig. I b) the ratio 
neopterin per CD4 +/CD8 + discriminated best 
between seronegatives and seropositives. Impor- 
tantly, using neopterin per CD4 + T-cell count or 
neopterin per CD4 +/CD8 + improved the discri- 
minatory potential when compared with the com- 
mon CD4 +/CD8 + ratio. 
Optimal cut-off values for each variable were 
determined at the largest Youden index (Table 2). 
The conclusions are consistent with those from 
Figs. 1 a and b (note that statistical comparisons 
were made only for the contrast between seronega- 
tives and seropositives; the number of AIDS pa- 
tients was regarded too small to allow meaningful 
statistical tests): of the Single variables, neopterin 
had the highest Youden index (Y=0.79) which is 
significantly higher than the value found for 
CD4 + T-cell number (Y-- 0.58, z = 2.66, two-sided 
P value= 0.0078. Of the composite variables, 
neopterin per CD4 +/CD8 + was best (Y= 0.87); 
this value being significantly higher than the result 
for CD4+/CD8+ T-cell ratio (Y=0.74, z=1.93, 
P=0.054). When the subjects were classified into 
three categories according to these optimal cut-off 
levels, the rate of correct classifications was 
118/144 (81.9%) for neopterin, 104/144 (72.2%) 
for CD4+,  110/144 (76.4%) for CD4+/CD8+,  
125/144 (86.8%) for neopterin per CD4 +, and for 
124/144 (86.1%) for neopterin per CD4 +/CD8 +. 
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Table 3. Rate of correct classifications by various multivariate models using neopterin concentration and CD4+ T-cell number 
as variables 
Correct classification 
Sero- Sero- AIDS Total 
negatives positives cases 
1. Linear discriminant analysis, 
equal pretest probabilities 
(Pl =P2 =P3 = 1/3) 
2. Same as (1), but correct pretest probabilities 
(Pl = 0.493, Pz = 0.444, P3 = 0.063 
3. Generalized likelihood ratio technique 
(Pl =P2 =P3 = 1/3) 
4. Generalized likelihood ratio technique 
(Pl =0.493, P2 =0.444, Pa =0.063) 
58/71 49/64 6/9 113/144 
(81.7%) (76.6%) (66.7%) (78.5%) 
59/71 51/64 5/9 115/144 
(83.1%) (79.7%) (55.6%) (79.9%) 
63/71 47/64 8/9 118/]44 
(88.7%) (73.4%) (88.9%) (81.9%) 
65/71 54/64 5/9 124/144 
(91.5%) (84.4%) (55.6%) (86.1%) 
For the analyses described here, the patients were divided into three categories (71 seronegatives, 64seropositives without AIDS, 
9 AIDS patients). First, by linear discriminant analysis using neopterin and CD4 + data, it was attempted to define classification 
functions allowing classification of patients to the correct diagnostic ategory (classification functions not shown). This was 
done twice, assuming two different sets of pretest probabilities (1, 2). As mentioned in the text, for each set of pretest probabilities 
separate discriminant analysis was necessary. Second, the same classification problem was treated using a recently described 
combination of a generalized likelihood ratio procedure and logistic regression analysis [13] which is described in some detail 
in the text. Again, two different sets of pretest probabilities were used (3, 4). Logistic regression analysis was necessary only 
once, recalculation for different pretest probabilities was done using formulae given in the text. Notably, both neopterin and 
CD4+ data were shown by discriminant analysis as well as by logistic regression analysis to be jointly significant, indicating 
that both variables added significant information. 
Multivariate Approach to Differentiate All Three 
Diagnostic Categories 
Analyzing in turn each of the three binary combi- 
nations of the diagnostic ategories, we performed 
logistic regression analyses using neopterin (x) and 
CD4+ T-cell count (y) as covariates. Thus, we 
obtained the following formulae for the logarith- 
mic likelihood ratio functions [log(LR)]: 
Seronegatives v seropositives: 
log (LRI 2) = - 0.020856x +0.0046371y 
- 0.039983 --log (71/64) 
Seronegatives v AIDS cases: 
log (LRt a) = -- 0.0079255x + 0.013438y 
-- 2.76710 -- log (71/9) 
Seropositives vs AIDS cases: 
log (LR23) = -- 0.0035428x + 0.0092473y 
+ 0.03967-- log (64/9) 
In these formulae, the logarithmic terms are 
needed to correct the constant erms for unequal 
frequencies of the diagnostic categories [1]; the 
weighting factors of the variables are the regression 
coefficients obtained by the logistic regression 
analyses. 
Using these results and the relationship LRij = 
1/LRji, and assuming either equal or observed pre- 
test propabilities PI, P2, P3 for the three diagnostic 
categories, posttest probabilities P1, P2 and P3 
were calculated for each subject inserting his indi- 
vidual test results into the following formulae [2]" 
P1 = 1/[1 -t- I/(LRa2 "P~/P2) 
+ 1/(LR,a "Pl/P3)] 
P2 = 1/[1 + 1/(LR2  "P /PO 
+ 1/(LR23 
P3 = 1/[1 + 1/(LR31 P3/Pl) 
+ 1/(LR3  "P3/P2)] 
For comparison, linear discriminant analyses 
were done on the same data set, whereby neopterin 
and CD4 + T-cell count were used as covariates. 
The rate of misclassfications was smallest when 
the described generalized likelihood ratio approach 
based on the logistic regression technique was 
used, and when the observed pretest probabilities 
were inserted (Table 3). 
Discussion 
This study confirms and extends results obtained 
on another cohort [7]: In patients infected with 
the HIV-I virus and in persons belonging to 
groups at high risk for HIV-1 disease, neopterin 
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concentrations are of use to discriminate anti-HIV- 
I seronegatives, seropositives without AIDS, and 
those with overt disease. For the discrimination 
between seronegatives and seropositives, neopterin 
was found to be superior to the CD4+ T-cell 
count. This difference was less expressed in the 
discrimination between seropositives and AIDS 
cases: here both variables offered a nearly perfect 
discrimination. This is in accord with the common 
experience that CD4 + T-cell counts are particular- 
ly low in advanced stages of the disease. 
Naturally, this study is not meant to replace 
serologic testing for HIV-1 for the diagnosis of 
the infection. Rather, it may be possible to define 
the roles of the various potential indicators of dis- 
ease progression. It must be stressed that our study 
suffers from the fact that the number of patients 
with AIDS is very low; therefore, the conclusions 
about the discrimination between seropositives 
without and with AIDS should be viewed as pre- 
liminary. 
The results are compatible with previous re- 
ports demonstrating a significant potential of 
neopterin concentrations and CD4 + T-cell 
numbers for prediction of the further course of 
disease in HIV-1 infected individuals. Serum [3] 
as well as urine concentrations of neopterin [8, 12] 
were found to aid significantly in the prognosis 
of HIV-1 infection, and similar results were found 
in a study of the prognostic value of neopterin 
in the present patients [11]. 
It has been proposed that the ratio between 
neopterin and CD4 + T-cells might offer advan- 
tages in assessing prognosis [4], and this has been 
extended and confirmed in another cohort [8]. Ad- 
ditionally it has been shown by Cox regression 
analysis that the combination of both variables has 
better predictive value than each single variable 
[12]. To define the behavior of the suggested com- 
posite variable in our patients, we have included 
neopterin per CD4 + T-cell count and, addition- 
ally, neopterin per CD4+/CD8+ in the present 
analysis. Our results indicate, that these variables 
are superior to neopterin or CD4 + T-cell number 
singly, and also to the common CD4 +/CD8 + T- 
cell ratio for monitoring progress of HIV disease. 
In addition to the univariate valuations by 
means of ROC curves and Youden indices, we 
were interested in the construction of a decision 
rule allowing conversion of pretest probabilities of 
the three diagnostic ategories into posttest proba- 
bilities based on measurements of neopterin con- 
centrations and CD4+ T-cell counts. The model 
used [13, 14] has been shown to yield a high rate 
of correct classifications when applied to our data 
set. It seems to be superior to linear discriminant 
analysis, and it has the advantage that it is most 
easily transportable to situations with quite differ- 
ent pretest probabilities. This important adjust- 
ment is not as easily done for the linear discrimin- 
ant models. There, a new computation of the mod- 
el is necessary for a new clinical setting, whereas 
the generalized likelihood ratio approach requires 
only adjustment of the constant erms but not a 
new logistic regression. Superiority to linear discri- 
minant analysis is probably due to greater obust- 
ness of the logistic approach against deviations of 
the distribution of values from multinormality. 
From the present study in combination with 
a variety of investigations by us and others the 
conclusion seems justified that neopterin measure- 
ment may be useful in the routine management 
of individuals infected with HIV-1. This simple 
biochemical marker for the activation of the cell- 
mediated immune system offers a sensitive and 
noninvasive tool for assessing the patient's clinical 
status and, as shown in other investigations, the 
prognosis. In combination with clinical informa- 
tion, an accurate system for staging HIV-I disease 
will probably be obtainable through the use of lab- 
oratory assays likely to include CD4+ T-cell 
count, neopterin, fl-2 microglobulin, and HIV-1 
p-24 antigen or antibody. Although further work 
is needed, to define the role for combinations of 
each of those markers, we have demonstrated that 
combined testing with CD4+ T-cell counts and 
neopterin is superior to each test used individually. 
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B6nner, G., Rahn, K.H. : Prostacyelin und Hypertonie. Sprin- 
ger, Berlin Heidelberg New York London Paris Tokyo Hong 
Kong 1988. X, 90 S., 43 Abb., 4 Tab., brosch. DM 22, -  
Das Buch Prostacyclin und Hypertonie wendet sich im Vor- 
wort an einen breiten Leserkreis: es will ,,jedem interessierten 
Arzt und Forscher helfen, sich ein eigenes Bild vonder physio- 
logischen und pathophysiologischen Bedeutung des vaskul/iren 
Prostaglandin PGI2 zu machen". Das Inhaltsverzeichnis zeigt 
dann, dab es sich um einen umfassenden und detaillierten Be- 
richt fiber die Erkenntnisse seit der Entdeckung des PGI2 1976 
bis 1987 handelt. Durch eine straffe Gliederung, eine pers6n- 
liche Stellungnahme am Ende jeden Kapitels und ein umfang- 
reiches Literaturverzeiehnis wurde versucht, einerseits das wis- 
senschaftlich genaue Detail, andererseits die ffir den interessier- 
ten Arzt notwendige (Jbersicht zu erzielen. - Folgerichtig wer- 
den zun/ichst die Biochemie und Pharmakologie des PGI2, das 
Wirkprofil und schlieglich die Bedeutung des PGI2 bei verschie- 
denen Formen der Hypertonie behandelt. Das Thema ist beson- 
ders schwierig, da bis vor einigen Jahren offensichtlich falsch 
hohe Werte ffir PGI2 gemessen wurden, derzeit immer noch 
groBe Unterschiede zwischen In-vitro- und In-vivo-Befunden 
bestehen und fiberdies meist noch unklar ist, bei welchen Pro- 
zessen PGI2 tatsfichlich eine pathophysiologische B deutung 
hat. Der mit der Literatur nach 1987 vertraute Leser kann sich 
oft der Meinung der Autoren nicht anschliel3en, da besonders 
bei Patienten mit Arteriosklerose h/iufig erh6hte PGIz-Plasma- 
konzentrationen berichtet werden. - Es bedarf der grfindlichen 
Fachkenntnis, iibersichtlich das komplexe Gebiet der Interak- 
tionen zwischen den vasopressorischen u d vasorelaxierenden 
Hormonen, welche den aktuellen Blutdruck bedingen, darzu- 
stellen. Dies ist den Autoren geglfickt. Besonderer Wert wurde 
auf die Bedeutung der vasorelaxierenden Komponente bei der 
Blutdruckregulation gelegt. Die einzelnen Befunde sind durch 
ein umfangreiches Literaturverzeichnis mit 275 Stellen belegt, 
welche alphabetisch geordnet sind. Sehr selten kommt es da- 
durch zu falschen Literaturangaben (S. 29, Tab. 2). Der Druck 
und die Ausstattung mit Tabellen lassen nichts zu wfinschen 
fibrig. - Insgesamt leidet das Buch an dem hohen Anspruch, 
einem so weiten Personenkreis genfigen zu wollen. Es bietet 
auf engstem Raum dem Leser eine umfassende Information 
fiber die Ergebnisse der Prostacyclinforschung bis 1987. Die 
weitergehenden Erkenntnisse konnten natiirlich nicht berfick- 
sichtigt werden. Durch die Ffille der Information ist das Buch 
nicht immer leicht zu lesen, die fibersichtliche Gliederung hilft 
abet bei der Orientierung und 1/il3t eine gezielte Information 
mit Hilfe des umfangreichen Sachverzeichnisses zu. 
O. Adam (Mfinchen) 
